Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hasanian Jilaihawi

Interventional Cardiology West Hollywood, CA Medical Doctor

NPI 1699020859 CMS profile 667894

8700 Beverly Blvd, West Hollywood, CA 90048

Open in the dashboard

General payments

$88,288

465 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$12,000

1 holding reported · through program year 2025

Research they led as principal investigator

$668,025 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Hasanian Jilaihawi of West Hollywood, CA is reported in the CMS Open Payments database as having received $88,288 across 465 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $668,025 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $12,000 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 91st percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29,569 100
2024 General $21,486 165
2023 General $8,437 101
2022 General $2,371 56
2021 General $7,280 8
2020 General $6,563 3
2019 General $12,582 32
2025 Ownership $12,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hasanian Jilaihawi
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Hasanian Jilaihawi were reported at $29,569. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Hasanian Jilaihawi Interventional Cardiology median Middle half National median
2019 $12,582 $1,097 $329–$3,048 $163
2020 $6,563 $473 $161–$1,480 $114
2021 $7,280 $677 $233–$1,827 $132
2022 $2,371 $978 $333–$2,724 $149
2023 $8,437 $1,136 $382–$2,986 $160
2024 $21,486 $1,181 $395–$3,326 $164
2025 $29,569 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $61,892 370 payments
  2. Medtronic Vascular, Inc. $18,418 22 payments
  3. Medtronic, Inc. $2,780 5 payments
  4. Abiomed $1,635 25 payments
  5. HeartFlow, Inc. $1,135 19 payments
  6. Boston Scientific Corporation $876 12 payments
  7. Philips Electronics North America Corporation $703 5 payments
  8. Abbott Laboratories $472 4 payments
  9. JenaValve Technology, Inc. $173 1 payment
  10. Ge Healthcare $146 1 payment
  11. Other $57 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $25,149 432 payments
  2. Consulting Fee $22,654 7 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20,500 4 payments
  4. Travel and Lodging $17,581 21 payments
  5. Grant $2,404 1 payment
Products named General payments · program years 2019–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $31,285 40 payments
  2. CoreValve Evolut $17,855 21 payments
  3. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $15,169 65 payments
  4. SAPIEN 3 Ultra RESILIA $13,010 231 payments
  5. FFRct $1,135 19 payments
  6. PASCAL $573 7 payments
  7. (9525) Intracardiac Und $521 1 payment
  8. Edwards SAPIEN 3 Transcatheter Heart Valve $489 5 payments
  9. EVOQUE $464 4 payments
  10. COREVALVE EVOLUT R $366 3 payments
  11. Other $1,282 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$7,796

Medicare's payments for the services billed

Medicare patients

26

Average age 66

Services billed

47

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Diabetes 73%
Heart failure 69%
Chronic kidney disease 58%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

465 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record